Viking Therapeutics (NASDAQ: VKTX) has captured the attention of investors, with its stock price skyrocketing over 400% in ...

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking ...

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $63.13, representing a +1.94% change from its previous close.

I'm bullish on Viking Therapeutics' weight-loss drug, but warn of risks and competition ahead. Click here to read my most ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $70.47 which represents a slight increase of $2.31 or 3.39% from the prior close of $68.16. The stock opened at $69.5 and ...

Buy VKTX near 55.07 target 75.66 stop loss @ 54.91 Details The technical summary data tells us to buy VKTX near 55.07 with an upside target of 75.66. This data also tells us to set a stop loss @ 54.91 ...

As of 20 September at 15:47 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

The weight-loss drug market has exploded over the past year, fueled by blockbuster GLP-1 breakthroughs from pharma giants.

In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other worst booming stocks to buy according to short sellers. September has historically ...